Letko, Brosseau & Associates’s Bausch Health BHC Stock Holding History
Bought
Maintained
Sold
Other funds holding BHC
IC
PC
GAM
LCM
N
MP
Letko, Brosseau & Associates's BHC Position: Q3 2022 in Review
Letko, Brosseau & Associates sold out of Bausch Health (BHC) in Q3 2022, closing a stake of 1,651,100 shares — an estimated $13.8M sold.
Letko, Brosseau & Associates first reported a position in BHC in Q3 2021 and held it in 4 quarters. The position peaked at $35.2M in Q4 2021. 283 funds tracked by Wall St. Rank hold BHC as of Q3 2022.
- Letko, Brosseau & Associates reported no remaining Bausch Health position as of Q3 2022 after selling out during the quarter.
- Letko, Brosseau & Associates sold 1,651,100 Bausch Health shares in Q3 2022, an estimated $13.8M.
- Letko, Brosseau & Associates first reported a position in Bausch Health in Q3 2021 and held it in 4 quarters.
- Letko, Brosseau & Associates's Bausch Health position peaked at $35.2M in Q4 2021.
- 283 funds tracked by Wall St. Rank held Bausch Health as of Q3 2022.
Based on Letko, Brosseau & Associates's 13F filing for Q3 2022, filed 10 Nov 2022.